Heat Recovery Steam Generator Market Is Poised To Grow At A 5.7% CAGR Through 2031

As per ESOMAR-certified consulting firm Future Market Insights (FMI), the global heat recovery steam generator market is anticipated to reach US 1.1 Bn in 2021. With the U.S., the U.K., Germany, and Japan emerging as key producers, the market is poised to grow at a 5.7% CAGR through 2031.

Get | Download Sample Copy with Graphs & List of Figures:
https://www.futuremarketinsights.com/reports/sample/rep-gb-441

In addition, government initiatives in counties such as the U.S., the U.K., India, and China regarding the promotion of renewable energy will spur demand for heat recovery steam generators in the forthcoming years.

Further, sophisticated customization and innovative product solutions offered by OEM’s and heat recovery steam generator players will continue providing tailwinds to sales.

As per FMI’s regional analysis, the U.K. is anticipated to lead the European heat recovery generator market. Stringent regulations regarding carbon emissions in the European Union, coupled with increasing adoption of renewable energy sources will enhance growth prospects through 2031.

“Increasing investments in the power generation sector to improve efficiency, coupled with inorganic growth strategies adopted by OEMs for better market reach will continue augmenting growth in the forthcoming years,” says the FMI analyst.

Key Takeaways:

  • Fully assembled heat recovery steam generators will remain the most preferred type of design.
  • In terms of configuration, horizontal drums will account for maximum sales.
  • Based on output power, 0-60 MW segment is poised to experience high demand.
  • Combined heat and power plants will dominate the application segment.
  • The U.S. is anticipated to witness high demand for heat recovery steam generators, owing to increasing energy production and need for sustainable methods. The North American market is poised to grow at a 4.4% CAGR.
  • The U.K. will continue leading the European heat recovery steam generator market, expanding at a 4.6% CAGR.
  • Demand for heat recovery steam generators will continue rising in China, due to rising adoption of combined cycle plants.
  • India will emerge as a lucrative market, owing to government-backed initiatives promoting renewable energy production.
  • Japan and South Korea will collectively account for 5% of the total market share.

For More Information or Query or Customization Before Buying, Visit:
https://www.futuremarketinsights.com/customization-available/rep-gb-441

Competitive Landscape

Cleaver-Brooks, Siemens AG, General Electric, CMI Group, John Wood Group PLC, Cannon S.p.A., Mitsubishi Hitachi Power Systems, Ltd., Rentech Boilers Systems Inc., Hamon Deltak, Inc., AC BOILERS SpA, SES Tlmače, a.s., and Xizi United Holdings Limited are some players operating in the heat recovery steam generator market profiled by FMI.

Top 5 players in the market include General Electric, Siemens AG, CMI Group, John Wood Group plc, and Mitsubishi Hitachi Power Systems Ltd., accounting for 75.5% of the total market share.

Leading players, as a part of their growth strategies, are focusing on strategic collaborations, mergers, and acquisitions to expand their global footprint and improve their product portfolios. For instance:

  • In August 2021, Siemens Energy and state-owned Egyptian Electricity Holding Co. have signed a memorandum of understanding to develop a hydrogen-based, including a 100-200 MW pilot electrolyzer facility for the clean energy industry.
  • In August 2021, Mitsubishi Power’s Philippines unit secured a three-year term service agreement to maintain boilers of the Davao coal plant of Aboitiz Power Corp. The agreement is intended to maintain reliable energy access in Mindanao.

Ask Us Your Questions About This Report:
https://www.futuremarketinsights.com/ask-question/rep-gb-441

Key Segments:

By Design Type: 

  • Modular Construction
  • C-Section Construction
  • Bundle Construction
  • Fully Assembled

By Configuration Type:

  • Horizontal Drum Units
  • Vertical Drum Units
  • Horizontal-Once Through Units

By Output Power Type:

  • 0-60 MW
  • 60-100 MW
  • 100 MW & Above

By Application Type:

  • Co-generation (Process Heating)
  • Combined Cycle
  • Combined Heat & Power (CHP)

By Region, Heat Recovery Steam Generator Market is segmented as: 

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • China
  • Japan
  • India
  • South East Asia & Others (SEA)
  • Middle East & Africa (MEA)

Neurointerventional Devices Market to grow at 7.8% CAGR and USD 5 billion in revenues by the end of 2030

Neurointerventional Devices Market – Outlook & Key Findings

  • Neurointerventional devices market to surge at 8% CAGR from 2020-2030
  • High incidence of brain aneurysm and associated neurological disorders to drive market growth
  • Faster patient recovery will accelerate coil embolization procedures in the long-run
  • Carotid stents shall capture a significant chunk of the market, attributed to rising number of carotid surgeries across prominent regions
  • Nanotechnology to play an influential role in endovascular intracranial aneurysms treatment
  • North America to witness maximum proliferation, with a market share exceeding 2/5th

A new report by Future Market Insights (FMI) expects global neurointerventional devices market to grow at 7.8% CAGR through 2030. According to the study, the market will reach USD 5 billion in revenues by the end of 2030.

Since the past several years, the burden of neurological disorders has increased multifold. According to the National Center for Biotechnology Information (NCBI), the frequency of cerebral aneurysm is nearly 3.2%, with the prevalence being higher amongst women than men above 50 years of age.

To remain ahead of your competitors, request for a sample: https://www.futuremarketinsights.com/reports/sample/rep-gb-871

It is estimated that around 6.5 million people in the United States possess an unruptured brain aneurysm, while 30,000 suffer a brain aneurysm rupture every year. Based on these trends, it is unsurprising to observe the market being interspersed with the presence of several reputed manufacturers who constantly launch new products.

In addition, rising prevalence of ischemic stroke is also boosting the neurointerventional devices market. Being non-invasive in nature, these devices increase chances of survival during surgery, further fueling market growth. By 2030, a valuation of US$ 4.8 Bn is predicted for the market.

Global Neurointerventional Devices Market- Key Takeaways

  • North America shall be the market hegemon, holding a 40.7% market share from 2020-2030
  • Embolic coils to capture the majority share, carotid stents to surge in popularity
  • High incidence of cerebral aneurysm to accelerate adoption of coiling procedures
  • Presence of experienced surgeons shall accelerate hospital-grade neurointerventional device adoption

COVID-19’s Impact on the Market

With respect to neurological disorders, several hospitals and clinics have reported complications in severely or critically ill patients with co-morbidities. COVID-19 has the potential to affect the central and peripheral nervous systems. The virus invades the brain either through the olfactory system or a hematogenous route. Once inside, the virus may cause hypoxic and metabolic abnormalities.

In this light, the neurointerventional devices market is poised to remain afloat in the near-term forecast period. Significant increases in mechanical thrombectomies were reported since April 2020, with majority of the patients seeking treatment for acute strokes from large vessel occlusions (LVOs).

A series of case studies on over 200 COVID-19 positive patients in Wuhan, China, 36.4% of patients exhibited neurologic symptoms such as acute cerebrovascular events, muscle injury and impaired consciousness. In this context, the market is poised to experience an adrenaline rush in the short-run.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-871

Competitive Intelligence

Some influential vendors within the landscape include: Stryker Corporation, Covidien Public Ltd., Penumbra Inc., Terumo Corporation, Johnson & Johnson Private Limited, Medtronic PLC, Boston Scientific Corporation and Abbott.

Players are emphasizing on expanding their businesses through partnerships, collaborations and mergers & acquisitions and participation in trade fairs. Many of them are also aligning with research institutes to augment their research capacities.

In August 2020, Stryker Corporation successfully launched its Surpass Evolve flow diverter after receiving FDA clearance in the U.S market. The device has already been in use in Europe since 2019.

In September 2020, Penumbra Inc. shall participate in the virtual Global Embolization Symposium & Technologies 2020 Conference. The company hopes to broaden its outreach and collaborate with other leading players to develop and launch new neurointerventional devices, thus expanding its existing product portfolio.

Key Segments Covered

Product

  • Embolic Coils
  • Intracranial Stents
  • Carotid Stents
  • Thrombectomy Devices
  • Intrassacular Devices
  • Balloons
  • Embolic Protection Devices
  • Liquid Embolics
  • Stent Retrievers

Technique

  • Neurothrombectomy Procedures
  • Cerebral Angioplasty
  • Stenting
  • Coiling Procedures
  • Flow Disruption

End User

  • Hospitals
  • Ambulatory Surgical Centers

For in-depth insights, Download a PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-871

Region

  • North America
  • Latin America
  • Europe
  • Middle East & Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

Bioimpedance Spectroscopy Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2031

According to the latest research by Future Market Insights, Bioimpedance Spectroscopy Market is set to witness a 9.3% growth during the year 2021-2031. The market has been a highly competitive market growing at a rapid rate and is expected to witness lucrative growth with the rapid increase of the number of obese population because of the unhealthy dietary patterns and sedentary lifestyles. Also, technological advancements and rise in government initiatives to encourage physical activity are the primary factors boosting the growth of this market.

What is Driving Demand for Bioimpedance Spectroscopy?

There are several factors that are boosting the market growth, that include increasing prevalence of metabolic disorders and a large pool of obese patients, rising awareness for health and fitness, and technological advancements.

In addition, key market players have likewise developed Bio-electrical Impedance Analysis (BIA) that is a non-invasive tool utilized by physicians to calculate the percentage of body fat.

Besides this, because of the current spread of coronavirus disease (COVID-19) worldwide, governments of different nations are investing in the development of healthcare infrastructure that is additionally creating a great demand for medical devices, which in turn drives the market of Bioimpedance spectroscopy.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13804

Increasing Pool of Obese Patients Likely to Fuel the Bioimpedance Spectroscopy Sales

The growing number of obese population is expected to boost demand for bioimpedance spectroscopy. Obesity is a metabolic disease and is mostly related with a broad range of chronic diseases, which can lead to significant growth in comorbidity and mortality. There is a rise in the percentage of obese population in involved in regular testing of body composition.

As per the data from World Obesity Federation, in 2018, the occurrence of obesity was very high in developed and high-income countries, like the United States at 42.8%, Belgium at 21.20%, and Australia at 31.3%. Yet, nations in the Pacific islands such as American Samoa (74.6%) likewise have some of the highest obesity rates across the world. The sales of bioimpedance spectroscopy have observed a rising pattern because of the obese population’s susceptibility to lifestyle disorders.

US and Canada Bioimpedance Spectroscopy Market Outlook

North America, majorly United States and Canada held the highest market in the Bioimpedance spectroscopy market. U.S. Bioimpedance spectroscopy market will witness significant growth due to rise in the obesity rates, rise in the number of health clubs and fitness centers and rise in the investments made by different governments.

Moreover, the presence of appropriate reimbursements in these countries will add to increase in acceptance of chronic illnesses appendicular lean mass. Also, growing prevalence of chronic diseases, particularly diabetes, is the key driver for US and Canada market development.

Europe Demand Outlook for Bioimpedance Spectroscopy

Europe is second-biggest market and is anticipated to register a significant growth because of the growing in aging population and the shift towards unhealthy lifestyle which leads to chronic diseases thus increasing the demand for bioimpedance spectroscopy.

The increase of the old age population will increase the demand for the body composition analyzers and this will in turn lead to the growth of the market. As per the United Nations report, in 2019, the number of the people in the world over 65 years of age or old age people is 703 million, contributing 13 per cent of global population. Europe has the highest percentage for geriatric population or people aged over 65 years of age (almost 25 per cent).

Who are the Key Manufacturers and Suppliers of Bioimpedance Spectroscopy?

Some of the leading manufacturers and suppliers of Bioimpedance spectroscopy include

  • Omron
  • Tanita
  • SMT Medical
  • Cerebrotech Medical Systems
  • ImpediMed
  • Bodystat
  • Selvas AI
  • Maltron International
  • Fresenius Medical Care
  • General Electric and others.

The Bioimpedance spectroscopy market is highly competitive, with the existence of a major players available in global markets, and various small participants in specific regional markets. In addition, a strong focus on the strategic development of their product portfolio through acquisitions & partnerships is projected to provide a strong position to the players in the market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13804

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Stress Tracking Devices Market Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031

According to the latest research by Future Market Insights, Stress Tracking Devices Market is set to experience positive growth during the year 2021-2031. The global stress tracking devices is witnessing demand every year as stress become apparent each year.

Prolong stress is known to have a negative impact on individuals. Therefore, the ability to track stress levels on convenient wearables or mobile devices can be very important.

Fitbit Sense will be the first wearable to track stress through electrodermal activity.

In 2021, a growing number of wearables will be tracking stress. Even before the Covid-19 pandemic, the majority of Americans reported experiencing daytime stress and nearly half said they felt they were worried about a lot. Covid-19 pandemic is only exacerbating stress levels.

Some leaders in the health-tech space, including Garmin, Whoop, Samsung Health and Oura, have previously used heart rate data to track stress levels.

What is Driving Demand for Stress Tracking Devices Market?

According to a recent study conducted at ITOnline, 66% of respondents use mobile apps to manage their health. A closer look at the study revealed that 79% of respondents were willing to manage their health through wearable devices.

It is expected to increase in number as the FDA encourages the development and use of mobile apps and stress tracking devices to improve healthcare and provide valuable health information to healthcare professionals.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13877

CardioChip (NeuroSky), the world’s smallest ECG chip, it contains an easy-to-use SDK that allows it to adapt to use in any wearable device.

According to Tracker IDC, about 5% of wear shipped worldwide last year came from Fitbit, below Apple’s 32% share. Aiming to challenge Apple together, Google agreed to buy the Fitbit in November 2020 for $2.1 billion.

Released in December 2020, Cove tracks stress via heart rate to a device that wraps around the back of the head, vibrates quietly from behind the ears, soothes the wearer and promotes better sleep. The vibration frequency of Cove was designed to stimulate nerve endings in the skin, activate the posterior insular cortex of the brain, and relieve stress.

Increasing Incidence of Stress Likely to Augment Stress Tracking Devices Sales

Some of the most common stressors, like money, work and family responsibilities, never change. However, in 2020, a number of new contenders appeared, including the Covid 19 pandemic, the controversial political atmosphere and more.

According to the American Psychological Association, 2020, about one-third of the world’s population reported feeling stressed, anxious or angry. About eight out of ten Americans reported that the coronavirus (COVID19) has induced stress.

According to The American Institute of Stress, It is estimated that U.S. industry spends more than $ 300 billion annually due to absenteeism, turnover, and reduced productivity, medical, legal and insurance costs due to work stress. Stress costs businesses an estimated $125 billion to $190 billion in additional health

U.S. And Canada Stress Tracking Devices Market Outlook

It is estimated that stress causes $300 billion in losses to the U.S. economy every year. According to a June 2015 study by the New York University Langone Medical Centre, more than 50% of smartphone users in the United States have downloaded health-related applications to their devices.

With the popularity of such health monitoring technologies, successful developers must ensure that their products continue to evolve to meet consumer needs and standards. Stress is affecting productivity in the workplace and is leading to an increase in sick and long vacations. Although stress can cause chaos in the professional world, it can also affect people’s personal lives and overall physical and mental health.

Europe Demand Outlook for Stress Tracking Devices

Work pressure is common throughout Europe. Ineffective work control between people is the main source of pressure, and the negative geopolitical situation in Europe threatens stability issues.

In Europe, according to data from the WHO, nearly 83 million of the European adult population are affected by mental disorders each year, and the proportion of women is higher than that of men. This means high demand for stress and anxiety devices. The market is witnessing the integration of artificial intelligence technology into test solutions to improve functionality.

Who Are The Key Manufacturers And Suppliers of Stress Tracking Devices Market?

Some of the key players operating in the stress tracking devices market are

  • Oura Health Oy.
  •  WHOOP
  • NeuroSky
  • Garmin Ltd
  • Fitbit Inc.
  • Apple Inc.
  • SAMSUNG
  • Pebble Technology Corp.
  • Google Inc.
  • Xiaomi Technology Co. Ltd.
  • Jawbone and Nike.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13877

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

RNA-Targeted Small Molecules market Trends, Strong Application Scope, Key Players, Growth Overview and Forecast by 2031

According to the latest research by Future Market Insights, RNA-Targeted Small Molecules Market is set to witness a 6.6% growth during the year 2021-2031. The market is a fragmented market growing at a slow rate and is anticipated to witness lucrative growth with the rising use of methodologies by major players; the market is projected to grow over the forecast period.

What is Driving Demand for RNA-Targeted Small Molecules

Factors such as development in genome mapping programs, the rising innovative developments, and increasing applications are anticipated to boost the market growth.

Moreover, technological advancements help in the market development. Technological developments has assisted analysts to collect vital information about public health and epidemiology studies, to sequence viruses and bacteria and help find causes that might add to the virulence.

Furthermore, the market is boosted by the advantages of rising number of mRNA-sequencing grants; mRNA-sequencing over traditional technologies; quick development in the precision medicine market; and increasing amount of research including RNA-seq.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13901

Growing Number of Cancer Cases, likely to Boost RNA-Targeted Small Molecules Sales

Cancer is one of the leading cause of death across the world. As per the American Cancer Society, around 1.8 million new cancer cases were diagnosed and around 606,520 cancer deaths occurred in 2020, in the United States. Hence, rising burden of a wide range of diseases among people, worldwide, is expected to boost the demand for the market.

There has been an increase in the utilization of advanced technologies, like combinatorial chemistry, bioinformatics, and high throughput for better drug candidate detection.

US and Canada RNA-Targeted Small Molecules Market Outlook

The US and Canada RNA-Targeted Small Molecules market is projected to observe a robust growth in the market due to the rise in presence of several cancer-relief organizations and campaigns in the US and Canada.

In addition, US has high opportunities for biosimilars, because biologics hold higher price. By 2021, the US market is expected to be one of the main competitors of biosimilars.

Moreover, beneficial government initiatives and upsurge in number of research partnerships are few of the factors projected to upsurge market growth.

Europe Demand Outlook for RNA-Targeted Small Molecules

Europe is anticipated to be second most lucrative region for market due to various factors.

The growing patient pool results into a high rate of RNA-targeted small molecules adoption due to the growing number of cancer patients.

In addition, rise in cancer patients, focus on merger and acquisition and funding by the governmental bodies by several major manufacturers is anticipated to lead to RNA-targeted small molecules market growth.

Who are the Key Manufacturers and Suppliers of RNA-Targeted Small Molecules

Some of the leading manufacturers and suppliers of RNA-Targeted Small Molecules include

  • AstraZeneca,
  • Pfizer,
  • Bentham Science,
  • PharmTech,
  • Nymirum Inc.,
  • Accent Therapeutics,
  • Anima Biotech Inc.
  •  Expansion Therapeutics
  • Bristol-Myers Squibb,
  • Novartis and others.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13901

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Patient Hygiene Aids Market Covid-19 Impact Analysis, Size, Share, Key Trends, Demand and Forecast till 2031

According to the latest research by Future Market Insights, Patient Hygiene Aids Market is set to experience 6.5% growth during the year 2021-2031. Patient hygiene refers to the practice of maintaining cleanliness of the patient. It includes of sanitizing, washing and cleaning.

The upliftment of maintance of patient hygiene is one of the primary factors leading towards the growth if the global patient hygiene aids market.

What is Driving Demand for Patient Hygiene Aids Market

Hygiene is a series of role performed to preserve health and prevent spread of diseases. Patient hygiene aids market includes of bathing regularly, handling foods, washing hands and sexual cleanliness. Some practices are gender specified. Furthermore, increasing opportunities in developing economies also form a lucrative opportunity for the market upliftment.

Moreover, growing patient hygiene aids health expenditure is also driving the demand for Patient Hygiene Aids Market sales.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13898

Growth in disposable income is Likely to Augment Patient Hygiene Aids Market

Increment in the disposable income also with growing health expenditure in patient hygiene aids market is like to augment the market growth.

Furthermore, growing awareness among people in developed region for enhancement of quality and health of life is attributed to drive the demand for patient hygiene aids market.

For instance, according to National Health Expenditure there was 4.6 % increment in U.S. for patient hygiene aids.

U.S. and Canada Outlook

U.S. and Canada are expected to have the highest share and therefore will dominate the Patient Hygiene Aids Market. This region is showing momentous growth over the forecast period.

Growing technological advancements and increasing population base along with growing disposable income will further augment the market growth in patient hygiene aids market in this region.

For instance, growing population along with increasing acceptance of personal hygiene have further lead to the increased usage of hygienic products and therefore significantly drive the patient hygiene aid market.

Europe Demand Outlook for Patient Hygiene Aids Market

The European market for Patient Hygiene Aids Market is estimated to grow at a considerable rate during the forecast period.

This surge is due to economic development, expansion in healthcare infrastructure and also increasing initiatives by public and private organizations for awareness about the patient hygiene aids in this region is like to augment the Patient Hygiene Aids Market.

Moreover, increase in availability of hygienic products to proliferate the consumption of patient hygienic aids is the major of the major factor driving the Patient Hygiene Aids Market in this region.

Who are the Key Manufacturers and Suppliers of Patient Hygiene Aids Market

Some of the key players operating in the Patient Hygiene Aids Market are

  • Syndy Pharma,
  • 3M,
  • Johnson & Johnson,
  • HARTMANN,
  • Unilever,
  • P&G,
  • Colgate-Palmolive Company,
  • B. Braun Melsungen,
  • Kimberly-Clark Corporation,
  • and Reckitt Benckiser Group.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13898

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Wound Skin Care Market 2021: Global Industry Analysis, Size, Share, Growth, Trends And Forecast To 2031

According to the latest research by Future Market Insights, Wound Skin Care Market is set to witness a 6.2% growth during the year 2021-2031. The market has been a semi-consolidated market growing at a rapid rate and is expected to witness lucrative growth with the rising number of patients with acute and chronic wounds, favorable reimbursement policies in emerging countries and the introduction of advanced products are anticipated to drive the market’s growth in the forecast period.

What is Driving Demand for Wound Skin Care?

There are various factors that are help in driving the wound skin care market. Wound caused by minor and major accidents are constantly increasing since few years whereby depend on effective medications and treatment for rapid healing. Various chronic diseases moreover contribute to the rising concern of the wounds worldwide.

The high rate of SSI (surgical site infection) occurrences in surgeries for patients with cancer and diabetes likewise requires the negative pressure wound therapy. The market growth in the healthcare sector is proved with the fact that around SSIs holds for 38% of all the nosocomial infections in surgical patients. This indicates the need for wound skin care management and treatment thus boosting the demand for the market.

The launch of advanced products and rising investment in research & development by market players is anticipated to boost the demand for these products, especially in emerging countries. This is leading to the market growth.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13882

Increasing prevalence of conditions & diseases affecting wound healing capabilities likely to drive the Wound Skin Care Sales

Physical health conditions, like acute wounds, surgical wounds and chronic wounds have an adverse effect on the wound healing process. The pervasiveness of surgical, chronic, and acute wounds has shown considerably growth over the past decade, mainly because of the rising worldwide geriatric population, the increasing prevalence of conditions like diabetes and obesity, increasing number of surgeries, and rising traumatic wounds. Obesity and diabetes can lead to growth in overall incidence and complexity of wounds like infections, chronic wounds, and ulcerations (leg or foot ulcers), which require treatments (wound management) and incur excessive medical expenses.

US and Canada Wound Skin Care Market Outlook

North America, majorly United States and Canada dominated the Wound Skin Care market. U.S. Wound Skin Care market will forecast significant growth due to rising cases of road accidents, sports injuries, and the presence of various major companies in the country.

Also, increase in prevalence of people suffering from various chronic diseases is anticipated to have a positive impact on the market growth. In addition, rise in initiatives undertaken by governments and authorities to develop healthcare systems and spread awareness regarding advantages of wound care products are furthermore projected to drive the growth of the market.

Europe Demand Outlook for Wound Skin Care

Europe is second-biggest market and is anticipated to register a significant growth because of the well-established infrastructure in countries like the Germany, U.K, etc., and hence rise in the adoption of innovative products in such countries.

Rising prevalence of diabetes is anticipated to drive the market growth over the forecast period. For example, as per the report North West Coast Strategic Clinical Networks of National Health Services, there were around 4.5 million individuals with diabetes in 2017 alone in the U.K. As per the same source, in 2017, approximately 200,000 diabetes patients are suffering from diabetic foot ulcers in U.K. Over 64,000 diabetes patients in Wales and England are expected to have foot ulcers at any given time. These factors add to the market growth over the forecast period.

Who are the Key Manufacturers and Suppliers of Wound Skin Care?

Some of the leading manufacturers and suppliers of Wound Skin Care include

  • Derma Sciences Inc. (Integra LifeSciences)
  • Medline Industries, Inc
  •  Advancis Medical USA LLC
  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Coloplast Corp.
  • Medtronic PLC
  • The 3M Company Smith & Nephew PLC

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13882

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Histoplasmosis Treatment market Insights with Upcoming Trends Segmentation, Opportunities and Forecast to 2031

The Histoplasmosis Treatment Market is looking forward to grow at a higher rate in the forecast period of 2021-2031. The rising investment by the government and public organizations to provide better healthcare quality is expected to augment the market demand. Furthermore, the increasing focus towards better healthcare system and the increasing geriatric populations, cancer cases and AIDS cases are the major drivers for the histoplasmosis market growth.

What is Driving Demand for Histoplasmosis Treatment Market

The demand for histoplasmosis treatment market has seen at a higher rate at a global level as there has increase in the number of chronic disease.

Furthermore, the rising ageing population and lack of hygiene is expected to drive the market. According to CDC 90% of the population in the US was infected as Histoplasmosis is common in the humid environment.

The incidence rate in adults about 65 years were in the ratio of 3.4 in 10,000 population. Globally, this disease is seen common in people with low immunity.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13913

The demand of histoplasmosis treatment market is on to the higher rate as malignant cases are never ending. These reasons have said to be the driving factors for histoplasmosis market in the given forecast period 2021-2031.

U.S. Histoplasmosis Treatment Market Outlook

U.S. is said to be the most dominating in terms of disease growth rate and will be the top one to boost the histoplasmosis treatment market.

This is due to the rising number in the malignant diseases, and immunocompromised patients.

According to CDC histoplasmosis is the commonest disease seen in HIV/ AIDS patients and due to their immunocompromised state 30% of them result in death.

This can be an opportunistic driving factor for the treatment market to grow. In addition, rising R&D and technological advancement in the region are some of the drivers of histoplasmosis treatment market.

Europe Demand Outlook for Histoplasmosis Treatment Market

The European market is considered the second largest market for histoplasmosis treatment at a global level.

The increasing focus on the healthcare facility, increase in the population of above 65 age group is likely to drive the market growth. Furthermore, the growing chronic diseases which diminishes the immunity of a person and AIDS in the region are boosting the demand for histoplasmois treatment market.

Who are the Key Manufacturers and Suppliers of Histoplasmosis treatment market.

Some of the key players operating in the Histoplasmosis Treatment Market are

  • Bristol Myers Squibb
  • Sigma tau pharmaceuticals Inc.
  • Three rivers pharmaceuticals
  • Astellas pharma US Inc.
  • Abbott laboratories
  • Abraxis pharmaceutical products
  • Teva parenteral medicines Inc.
  •  X gen pharmaceuticals Inc.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13913

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Malaria Ag rapid Testing Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2031

According to the latest research by Future Market Insights, Malaria Ag rapid Testing Market is set to experience 5% growth during the year 2021-2031.

Malaria Ag rapid testing kits allows for quick detection of malarial antigen present in human body without the use of microscopes or in lab set-ups.

Primary advantage of using a rapid testing kit is its ease of collection, cost effectiveness, safety and user friendly.

What is Driving the Demand for Malaria Ag Rapid Testing Market

Malaria Ag rapid testing or rapid diagnostic test are lateral flow immunochromatographic antigen detection test, usually available in test strip or cassette form. These test detect the presence of malarial parasite antigen, in an infected human blood giving results within 15 minutes. Such procedures are simple, safe and easier for quick diagnosis of malaria at an initial stage and does not require special equipment or training.

An increasing number of cases of malaria in tropical countries along with increasing travelers visiting these countries, and in turn getting infected by malaria, can be seen rising in recent years.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13904

Also the unavailability of lab testing for diagnosis of malaria in most endemic countries has further increased the necessity for the malaria antigen rapid tests.

A per the 2019-20 report by World Health Organization (WHO), an estimated 229 Mn cases of malaria was found globally in 87 malaria-endemic countries in 2019.

Of which, 05 countries in Africa region namely, Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda (5%), Mozambique (4%) and Niger (3%), accounted for about 51% of the global cases.

Thus, the demand for the Malaria Ag rapid testing market is likely to provide incremental opportunity in the forecasted period.

Which Factors are likely to Augment the Growth of the Malaria Ag Rapid Testing Market

The field of malaria Ag rapid testing market is witnessing series of advancements and is further expected to offer effective diagnostic solutions for infections caused by malaria.

An increasing number of deaths caused due to non-diagnosis of malaria at early stages and increased resistance of parasite especially

P.falciparum to anti-malarial drugs has increased the need for these rapid diagnostic tests to diagnose the disease at the earliest and provide for treatment of same.

As per the 2019-20 report by World Health Organization (WHO), 67% (274,000) of the total deaths caused by malaria, at global level, consisted of children below 5 years of age, in 2019.

Investment in malaria programs and research & development for malaria control and elimination are being undertaken by government and industry players in various regions. Various Public and private sector organizations are also playing major role in promoting and supporting the clinical development of key products.

A per the 2019-20 report by World Health Organization (WHO), an estimated US$ 3 Bn was the total funding provided for malaria control and elimination.

Out of this total, US$ 900 Mn (31% of total funds) of funding was contributed by the government of endemic countries.

It is thus, expected for the malaria Ag rapid test market to seek a growth in the forecasted period.

Some of the key players of Malaria Ag rapid testing include

  • Abbott
  • Accuquik™ Test Kits (USA) Advy Chemical Pvt. Ltd.
  • Arkray Healthcare Pvt Ltd
  • CTK Biotech Inc.
  •  Biotrol laboratories Pvt. Ltd.
  • malarex Limited (UK)
  • Alere
  • Ameritek Inc.
  • Apacor ltd.
  • Atmo Diagnostics

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13904

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Repositioning and Offloading Devices Market Perspective, Comprehensive Analysis, Growth and Forecast 2021-2031

According to the latest research by Future Market Insights, the Repositioning and Offloading Devices Market is set to experience 6% growth during the year 2021-2031.

Repositioning and offloading devices are particularly used for the treatment of diabetic foot ulcers.

These ulcers in the diabetic person are caused due to poor circulation in a particular area, hyperglycaemia or any nerve damage. During the treatment of diabetic foot ulcers, pressure modulation also known as offloading is used to mitigate the pressure from a particular area.

What is the Driving Demand for Repositioning and Offloading Devices

The main aim of offloading devices is to mitigate the pressure and promote healing. The drivers for this market can include the recurrence of ulceration in the diabetic foot.

The growth of this market is anticipated due to the rise in the prevalence of diabetes. According to research, diabetes-related foot ulceration (DFU) affects 26 million people annually worldwide and results in large mortality.

To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/REP-GB-13944

The increasing geriatric population are more prone to diabetes and DFU. According to a UN report, the geriatric population is expected to increase by 16% by 2050. This may act as a driver for the market. Apart from DFU, different pressure ulcers are caused majorly due to immobility. This is particularly seen in elderly people and patients with spine or back injuries.

These injuries restrict the movement of the patient, due to which pressures are created on specific body parts.

The increase in the number of surgeries and the development of pressure ulcers will drive the market.

The repositioning devices are particularly used to move the patient from one place to another. This may include shifting them from one department o hospital to another. For example, shifting them from outpatient department to inpatient department or ICU. The rise in the prevalence of accidents and injuries drives this market.

Impact of Covid on Repositioning and Offloading Device Market

In March 2020, WHO declared the outbreak of Covid-19 as a pandemic. Like any other sector, the healthcare sector was also tremendously impacted by it.

Due to restrictions, the lifestyle of the people changes and became sedentary. This sedentary lifestyle has led to an increase in chronic disorders, diabetes and the occurrence of pressure ulcers.

To combat the deadly virus, the hospitals were asked only to perform essential surgeries. For the movement of patients post-surgery repositioning devices were used. Hence, COVID-19 had a positive impact on this market.

Who are the Key Manufacturers and Suppliers of Repositioning and Offloading Devices

Some of the key players operating in the repositioning and offloading devices Market are

  • Mölnlycke Health Care AB
  • Beechfield Healthcare Ltd
  • Next Health
  • LLC
  • Sage Products LLC
  • Stryker
  • Seneca Devices Inc.
  • Guldmann
  • Hill-Rom Services
  • Frontier Medical Group
  • Walgreen Health Solutions
  • LLC Arjo
  • Next Health LLC.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-13944

Why Future Market Insights?

  •   Comprehensive analysis on evolving purchase pattern across different geographies
  •   Detailed insights of market segments and sub-segments for historical as well as forecast period
  •   A competitive analysis of prominent players and emerging players in the keyword market
  •   Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com